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Bacterial -2-macroglobulins have been suggested to function in defence as
broad-spectrum inhibitors of host proteases that breach the outer membrane.
Here, the X-ray structure of protease-cleaved Escherichia coli -2-macro-
globulin is described, which reveals a putative mechanism of activation and
conformational change essential for protease inhibition. In this competitive
mechanism, protease cleavage of the bait-region domain results in the
untethering of an intrinsically disordered region of this domain which disrupts
native interdomain interactions that maintain E. coli -2-macroglobulin in
the inactivated form. The resulting global conformational change results in
entrapment of the protease and activation of the thioester bond that covalently
links to the attacking protease. Owing to the similarity in structure and domain
architecture of Escherichia coli -2-macroglobulin and human -2-macro-
globulin, this protease-activation mechanism is likely to operate across the
diverse members of this group.
1. Introduction
-2-Macroglobulins (2Ms) are found in eukaryotic blood,
invertebrate haemolymph, the eggs of birds and reptiles, and
the bacterial periplasm, where they are thought to play a role
in the restriction of proteolytic cleavage (Sottrup-Jensen,
1989; Lin et al., 2002; Budd et al., 2004; Li et al., 2004; Doan &
Gettins, 2008). Eukaryotic 2Ms have been shown to play
important roles in regulating the proteolytic cleavage of a
wide range of proteases and are involved in processes such as
fibrinolysis and coagulation (De Boer et al., 1993). Bacterial
2Ms (BA2Ms) are produced by a wide range of Gram-
negative bacteria ranging from human pathogenic and
commensal strains to plant pathogens and marine bacteria
(Budd et al., 2004). Escherichia coli 2M (ECAM) contains
the conserved thioester bond that is characteristic of the 2Ms
and which is essential for covalent binding to cleaving
proteases (Budd et al., 2004; Doan & Gettins, 2008; Neves et
al., 2012).
The gene encoding ECAM, yfhM, is frequently found in an
operon with pbp1C, which encodes penicillin-binding protein
1C (Pbp1C; Budd et al., 2004; Doan & Gettins, 2008). Pbp1C is
predicted to be a bifunctional transpeptidase and transglyco-
sylase owing to its homology to Pbp1A and Pbp1B, which are
both essential for the synthesis of the peptidoglycan layer
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(Schiffer & Ho¨ltje, 1999; Budd et al., 2004). Both ECAM and
Pbp1C are periplasmic proteins that are anchored to the inner
membrane and have been proposed to function together in
defence and repair against proteases that damage the bacterial
cell wall (Budd et al., 2004). Specifically, it has been postulated
that the host proteases produced in defence against bacterial
infection, which gain access to the periplasmic space, are
inhibited by ECAM, with Pbp1C acting to repair damage
(Budd et al., 2004).
The overall structure of 2Ms comprises a series of -sheet
sandwich macroglobulin (MG) domains forming a ‘keyring’
shape, a bait-region domain (BRD) spanning the body of the
ring, a mostly helical thioester domain (TED) connected to
the ‘keyring’ by a complement protein subcomponent (CUB)
domain, and a C-terminal MG (CTMG) domain (Janssen et al.,
2005; Marrero et al., 2012; Wong & Dessen, 2014). Within
eukaryotic 2Ms there are eight MG domains including
CTMG, which is also known as the receptor-binding domain
(MG1–MG7, CTMG), while BA2Ms contain ten MG domains
including two N-terminal MG domains anchoring the protein
to the inner membrane within the periplasm (MG1–MG9,
CTMG) (Huang et al., 1998; Doan & Gettins, 2007; Marrero
et al., 2012; Wong & Dessen, 2014). The TED contains a
conserved CXEQ motif where a thioester bond is formed,
which on activation can covalently link the 2M to lysine
residues on the surface of the attacking protease (Sottrup-
Jensen et al., 1980, 1989; Osterberg & Malmensten, 1984;
Jacobsen & Sottrup-Jensen, 1993; Janssen et al., 2005; Abdul
Ajees et al., 2006; Marrero et al., 2012; Wong & Dessen, 2014).
2Ms are activated through the protease cleavage of a largely
disordered bait region, which results in a conformational
change that both traps the protease in a cage-like structure
and exposes the highly reactive thioester bond (Travis &
Salvesen, 1983; Sottrup-Jensen, 1989; Sottrup-Jensen et al.,
1989; Doan & Gettins, 2008).
In human 2M, chemical cleavage of the thioester bond by
methylamine results in a large conformational change that has
been interpreted by electron microscopy as similar to that
observed on protease cleavage (Sottrup-Jensen et al., 1980;
Tapon-Bretaudie´re et al., 1985; Dodds et al., 1996; Dodds &
Law, 1998; Marrero et al., 2012). In contrast, the recently
elucidated structures of the BA2M from Salmonella enterica
serovar Typhimurium (SaA2M) in its unactivated and
methylamine-activated forms show that although the overall
domain structure of BA2Ms is highly similar to that of human
2M, there is no major conformational change of the bacterial
form on chemical cleavage of the thioester bond (Doan &
Gettins, 2008; Neves et al., 2012; Wong & Dessen, 2014). In the
structures of both bacterial and eukaryotic 2Ms the thioester
bond lies close to the surface of the TED, but is protected from
hydrolysis by a hydrophobic pocket at the interface between
the TED and the CTMG domain (Janssen et al., 2005; Le et al.,
2012; Wong & Dessen, 2014).
Owing to a lack of detailed structural information on
protease-cleaved forms of 2M, the mechanism through which
cleavage of the BRD activates 2M is not known. However, it
has been suggested that upon cleavage within human 2M the
cleaved BRD interacts with MG2 (MG4 in BA2M), resulting
in conformational activation (Marrero et al., 2012). Alter-
natively, within human 2M it has been suggested that the bait
region interacts with the TED, the MG6 (MG8 in BA2M) and
the CUB domains (Marrero et al., 2012). However, in the
absence of a crystal structure of a protease-cleaved form of
2M the mechanism of protease-induced activation remains
speculative.
To elucidate the mechanism of protease-induced 2M
activation, we crystallized and solved the X-ray structure of a
porcine elastase-cleaved form of ECAM, a close homologue of
SaA2M (81% amino-acid sequence identity) for which the
structure of the unactivated form was recently solved (Wong
& Dessen, 2014). Interestingly, the structure of protease-
activated ECAM is highly similar to that of chemically acti-
vated human 2M (12% amino-acid sequence identity) and
reveals a clear mechanism of how conformational rearrange-
ment is triggered on protease cleavage. Key to activation is
the untethering of the intrinsically disordered bait region on
cleavage, allowing this disordered region of polypeptide to
outcompete the domain–domain interactions that normally
maintain the thioester bond in its unactivated form. This
suggests a general mechanism through which members of the
large and important 2M superfamily are activated.
2. Materials and methods
All chemicals were purchased from Sigma unless mentioned
otherwise.
2.1. Cloning and protein purification of ECAM
The gene for ECAM, yfhM from E. coli K-12, was amplified
by PCR and cloned into pET-21a vector using NdeI and XhoI
restriction sites. The first 22 residues from the N-terminus of
the gene, containing a signal sequence identified using
SignalP, were excluded from the construct. The stop codon
was also excluded, resulting in a protein consisting of residues
23–1631 and a C-terminal 6His tag (LEHHHHHH). ECAM
was initially overexpressed in E. coli BL21(DE3) cells and
subsequently in T7 Express Crystal Competent E. coli cells
(methionine-auxotrophic strain, New England Biosciences)
using an inducible T7 promoter with 1 mM isopropyl -d-1-
thiogalactopyranoside (IPTG) as the inducer. Bacteria
expressing ECAM were grown in lysogeny broth; seleno-
methionine-labelled ECAM was obtained using M9 minimal
medium supplemented with 50 mg l1 selenomethionine and
20 mg l1 of each of nine essential amino acids (excluding
methionine). Cells were grown at 37C to an OD600 of 0.6,
protein production was induced by the addition of 1 mM
IPTG and the cells were grown for a further 6 h. The cell pellet
was collected by centrifugation at 4400g for 15 min and the
cells were resuspended in binding buffer [20 mM Tris, 10 mM
imidazole, 500 mM sodium chloride, 5 mM tris(2-carboxy-
ethyl)phosphine (TCEP) pH 7.5] and lysed by sonication with
1 mg ml1 lysozyme in the presence of protease inhibitors
(Complete Mini, Roche). Cell debris was removed by centri-
research papers
Acta Cryst. (2015). D71, 1478–1486 Fyfe et al.  Protease-cleaved E. coli -2-macroglobulin 1479
fugation at 46 000g for 30 min at 4C. The cell supernatant was
then loaded onto a HisTrap HP column (GE Healthcare) and
the bound protein was eluted with elution buffer (20 mM Tris,
500 mM imidazole, 500 mM sodium chloride, 5 mM TCEP pH
7.5) using a linear gradient increasing from 10 to 500 mM.
Fractions containing ECAM were pooled and dialysed over-
night at 4C into 50 mM Tris, 200 mM sodium chloride pH 7.5
and run on a Superdex S200 gel-filtration column (GE
Healthcare). Central fractions from the peak were combined
and concentrated using a 100 kDa molecular-weight cutoff
centrifugal concentrator.
2.2. Crystallization and structure building
Purified ECAM was reacted in a 1:1 molar ratio with
porcine elastase (MP Biomedicals) in 50 mM Tris, 200 mM
NaCl pH 7.5 on ice for 5 min before being loaded onto a
Superdex S200 gel-filtration column (GE Healthcare). The
two major peaks from gel filtration were concentrated to
16 mg ml1 separately using 100 kDa molecular-weight cutoff
centrifugal concentrators and used in crystallization trials.
Several hundred crystallization conditions were tested,
including the JCSG-plus, MIDAS and Morpheus screens
(Molecular Dimensions), for both concentrated peaks. A
Cartesian Honeybee 8+1 (Harvard Bioscience) robot was used
with 96-well plates, dispensing 0.5 ml reservoir solution and
0.5 ml protein sample. Subsequent scaled-up crystal growth
was performed using 2.5 ml reservoir solution and 2.5 ml
protein sample. The initial crystal was grown in conditions
consisting of 0.1M potassium chloride, 0.1M HEPES, 25%
Sokalan CP 7 pH 7.0, and upon optimization the pH was
adjusted to 7.5 for larger crystal growth. Crystals were grown
using equal volumes of protease-cleaved ECAM and reservoir
solution using sitting-drop vapour diffusion, with crystals
appearing after 2 d at 16C for the second fraction and after
two weeks for the first fraction. Cryoprotection was optimized
with a 3:2 ratio of xylitol-saturated reservoir solution to
reservoir solution. Crystals were briefly soaked and flash-
cooled in liquid nitrogen for data collection. The best
diffraction resolution obtained was 3.8 A˚, and molecular
replacement with methylamine-activated 2M (PDB entry
4acq) was unsuccessful, most likely as the sequence identity
with the human homologue was low (12%) and owing to the
difference in domain orientation between the structural
models (Marrero et al., 2012). Further expression was
performed using a methionine-auxotrophic strain of E. coli
BL21 (T7 Express Crystal Competent E. coli, New England
Bioscience) and the purification and crystallization screens
were repeated using selenomethionine-labelled protein. As
repeating the previous protocol with selenomethionine-
labelled protein was unsuccessful, in situ proteolytic cleavage
screening was performed using porcine elastase. Successful
crystallization was achieved using a 1:100 ratio of porcine
elastase to selenomethionine-labelled ECAM. Crystallization
was successful in the same condition as used previously, with
the crystal having a similar appearance and the same space
group as previous unlabelled crystals. These crystals diffracted
to 3.65 A˚ resolution and phases were obtained using single-
wavelength anomalous diffraction (SAD).
Data were collected for ECAM crystals on the I02, I03 and
I24 beamlines at Diamond Light Source, Didcot, England at
100 K at the Se K edge ( = 0.97939 A˚) using a PILATUS 6M
detector. A high-redundancy SAD data set was processed and
scaled using XDS and AIMLESS from the CCP4 suite of
programs (Evans, 2006; Kabsch, 2010; Winn et al., 2011).
Selenium sites were located using SHELXC/D, with the best
substructure solution consisting of 23 sites (Sheldrick, 2010).
These selenium sites were input along with the SAD data set
to AutoSol within the PHENIX package to perform phasing
and density modification (Terwilliger et al., 2009). Density
modification in AutoSol was sufficient to break the phase
ambiguity owing to the high solvent content of the crystal
(69%). This yielded interpretable, low-resolution maps in
which density corresponding to secondary-structure elements
and larger amino-acid side chains was visible. Initially, the
-helical TED domain was built in Coot using idealized
-helical sections (Emsley et al., 2010). The loops between
these sections were connected where density was available.
The six selenomethionine sites in this domain provided the
starting sites for the building of amino-acid side chains in the
TED domain, although owing to the resolution initially only
larger side chains and those where continuous sequence could
be determined were built. In addition to the building of the
TED domain, a number of 2M-derived polyalanine MG
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Table 1
Data-collection and refinement statistics (single-wavelength anomalous
diffraction) for protease-cleaved ECAM.




Unit-cell parameters (A˚, ) a = b = 176.06, c = 161.13,
 =  = 90,  = 120
Resolution (A˚) 46.87–3.65 (4.00–3.65)
Solvent content (%) 69
No. of reflections 20753 (4991)
CC1/2 0.998 (0.675)
Rmerge (%) 39.0 (378.0)
Rp.i.m.† (%) 7.7 (74.4)
hI/(I )i 13.2 (2.1)
Completeness (%) 99.9 (99.9)
Multiplicity 26.6 (26.7)
Anomalous completeness (%) 99.9 (99.3)
Anomalous multiplicity 12.8 (12.8)
DelAnom correlation between half sets 0.335 (0.011)
Mid-slope of anomalous normal probability 1.245
Refinement
Rwork/Rfree (%) 17.7/23.8
No. of atoms 8699
Average B factor (A˚2) 144
R.m.s. deviations
Bond lengths (A˚) 0.01















‡ Percentages of residues in favoured/allowed regions calculated by MolProbity (Chen
et al., 2010).
domains were rigid-body fitted into their corresponding
density and manually real-space refined in Coot (Emsley et al.,
2010). As with the TED domain, where possible side chains
were fitted using the positions of selenomethionine Se atoms
as starting sites. This initial building yielded a partial model,
which was then used in conjunction with the selenomethionine
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Figure 1
Crystal structure of porcine elastase-cleaved E. coli 2M (ECAM). (a) Schematic representation of the 13 domains of ECAM showing the macroglobulin
domains (MG) including the C-terminal MG (CTMG) domain, the bait-region domain (BRD), the complement protein subcomponent (CUB) domain
and the thioester domain (TED) containing the CLEQmotif. (b) The structure of elastase-cleaved ECAMwith the individual domains coloured as in (a).
Smaller van der Waals surfaces in both views are also presented. In the left view the -helical TED is orientated with the CLEQ thioester (drawn as red
van der Waals spheres) positioned above the pocket which is thought to accommodate the attacking protease. (c) Structural alignment of methylamine-
treated human 2M (PDB entry 4acq monomer trimmed to the domains present in cleaved ECAM) and elastase-cleaved ECAM (PDB entry 4rtd) in
green and red, respectively. (d) Structural alignment of native SaA2M (PDB entry 4u48 trimmed to the domains present in cleaved ECAM) and elastase-
cleaved ECAM (PDB entry 4rtd) in blue and red, respectively. Structural alignments were performed using the MG domain containing the bait region
(shown in orange).
substructure to rephase the experimental data using MR-SAD
phasing in Phaser (McCoy et al., 2007). This process led to
phase improvement and the appearance of new features in the
map, which were modelled, and the process was repeated
iteratively. Partway through the building process the atomic
coordinates for SaA2M were published (PDB entry 4u48;
Wong & Dessen, 2014), and the domains from this model
provided validation of the MG-domain placement and side-
chain modelling in our experimentally phased map. The
SaA2M structure also provided a template for building the
more difficult sections of the model. At this point restrained
TLS refinement using REFMAC5 was found to stably improve
both Rwork and Rfree, and refinement was performed and
the model was improved and finished manually in Coot
(Murshudov et al., 2011; Emsley et al., 2010). Electron density
for the thioester bond indicated that the deaminated gluta-
mine forms no covalent bond to the cysteine. Before submis-
sion of the final model, the quality of the structure was
assessed using the MolProbity webserver (Chen et al., 2010).
The atomic coordinates and structure factors were deposited
in the Protein Data Bank (PDB entry 4rtd). Statistics for data
collection, experimental phasing and refinement are presented
in Table 1. For mass-spectrometric analysis of protease-
cleaved ECAM, crystals were washed in reservoir solution
before being dissolved in deionized water and heated to 96C
in bromophenol blue sample buffer for 5 min. The sample was
then run on a NuPAGE Novex 4–12% bis-tris gel (Invitrogen)
and visible bands were cut for proteomic analysis. Samples
were digested by trypsin and analysed by LC-MS/MS (Orbi-
trap XL) performed at the Fingerprints Proteomics Facility at
the University of Dundee.
3. Results
3.1. Overall structure of protease-activated ECAM
To determine the structural changes that occur on protease
cleavage of ECAM, we performed protease digestion with
porcine elastase and used the major products from gel filtra-
tion of cleaved ECAM to perform crystallization trials. This
yielded diffracting crystals in 0.1M potassium chloride, 0.1M
HEPES, 25% Sokalan CP 7 pH 7.0 with cleaved ECAM. In
order to obtain phase information, we attempted to repeat this
process with selenomethionine-labelled ECAM, but this failed
to yield crystals. However, an alternative strategy of in situ
proteolysis and crystallization with selenomethionine-labelled
ECAM was successful. This method yielded crystals that
diffracted to 3.65 A˚ resolution. Upon completion and valida-
tion of the model of protease-activated ECAM, the number of
Ramachandran outliers remaining was appropriate for a
crystal structure with a resolution of 3.65 A˚. Although the
Rmerge and Rp.i.m. values were high, this can be explained by the
highly redundant data set used; with a CC1/2 of 0.675 in the
highest shell, these data used were judged to be acceptable
(Karplus & Diederichs, 2012; Diederichs & Karplus, 2013).
Similar to the domain architecture of native SaA2M,
uncleaved ECAM consists of ten MG domains, with a largely
disordered bait-region domain found within MG8, a TED
that houses the reactive thioester bond and a CUB domain
(Fig. 1a). Elastase-cleaved ECAM (Fig. 1b) adopts a confor-
mation similar to that of methylamine-activated human 2M
(Fig. 1c) but distinct from the unactivated form of SaA2M
(Fig. 1d). Despite the low sequence identity between human
2M and ECAM (12%), the r.m.s.d. between C atoms for
these proteins is 14.1 A˚, while that for SaA2M and ECAM,
which share 82% sequence identity, is 22.1 A˚. Most notably, in
the structure of the protease-cleaved ECAM, interactions
between the TED and the CTMG domain, which protects the
thioester bond in unactivated SaA2M, are not present.
Instead, the thioester region of TED is solvent-exposed and
faces the expected location of the attacking protease, as it
would be positioned when cleaving the bait region of ECAM
(Fig. 1b). Electron density for elastase, in addition to that for
MG domains 1, 2, 3 and 7, was absent in 2Fo  Fc maps of
cleaved ECAM, as was electron density for 20 amino-acid
residues (Arg923–Leu942) within the bait region. Analysis of
elastase-cleaved ECAM by SDS–PAGE and mass spectro-
metry confirms that MG domains 1, 2, 3 and 7 are absent from
research papers
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Figure 2
Bait-region interaction with the CTMG domain. (a) Here we show
hydrogen bonding between the cleaved bait region (blue) and the CTMG
domain (grey) as dashed yellow lines. Note the interaction between
Arg956 and Met1634, with the CTMG methionine normally involved in
the hydrophobic pocket found in uncleaved native SaA2M. MG4 and
MG9 are shown in yellow and red, respectively. (b) Surface representa-
tion of the CTMG domain bound to the TED in SaA2M (blue) overlaid
(by superposition of CTMG domains) with the previously disordered bait
region bound to the CTMG domain in elastase-cleaved ECAM (red). The
thioester bond within the TED is shown as dark blue van der Waals
spheres.
the crystallized protein (Supplementary Fig. S1). Two bands at
90 and 75 kDa on SDS–PAGE have similar peptide coverage,
encompassing the same domains (Supplementary Fig. S1).
However, the reason for the difference in apparent molecular
weights between these two species is not known.
3.2. Interaction of the BRD with the CTMG domain
Although it is known that protease cleavage of the largely
disordered bait region of both human and bacterial 2Ms
gives rise to a large conformational rearrangement and acti-
vation of the thioester bond, the mechanism through which
this is mediated was unclear (Barrett et al., 1979; Neves et al.,
2012). However, the structure of protease-cleaved ECAM
provides a clear mechanism for this process. Thioester bond
release is achieved by the untethering of a large region of an
unstructured polypeptide chain upon cleavage of the BRD
that forms new interactions with the CTMG domain, thereby
preventing the protective interaction with the TED. Specifi-
cally, in the elastase-cleaved form of ECAM additional resi-
dues (Phe947–Asn963) of the BRD are observed that are
disordered in the uncleaved SaA2M structure. All of these
residues in the protease-cleaved ECAM structure are ordered
owing to the formation of a new binding interface between
the BRD and the CTMG domain upon protease cleavage
(Fig. 2a). Critically, the region of the CTMG domain that is
involved in BRD binding substantially overlaps with the
region of the CTMG domain that forms the binding interface
with the TED in the uncleaved form of the protein (Fig. 2b).
The buried surface area between the CTMG domain and TED
in SaA2M is 1972 A˚2, with three hydrogen bonds between
these domains, whereas the buried surface area between the
elastase-cleaved BRD and the CTMG domain in ECAM is
1438 A˚2, with five hydrogen bonds between the domains. In
the protease-cleaved ECAM, hydrogen-bond formation
between residues of the CTMG domain and the cleaved bait
region involves the highly conserved RDDR and EXMY
motifs (Fig. 3). Interestingly, it is residues within these motifs
that also form hydrogen bonds to the TED in the uncleaved
SaA2M protein (Fig. 3; Wong & Dessen, 2014).
3.3. Cleavage-induced conformational changes and thioester-
bond activation of a2Ms
We propose that the loss of the interaction of the TED with
the CTMG domain is sufficient to enable both the large TED
movement observed in the cleaved ECAM structure relative
to the unactivated SaA2M structure and the exposure of the
thioester bond (Fig. 4a, Supplementary Movie S1). The
movement of the TED domain shows an overall shift of 36 A˚,
with the MG6 domain moving by 50 A˚ and with both the MG6
and TED arms hugging the position at which the attacking
protease would be located to cleave the BRD (Fig. 4a,
Supplementary Movie S1). In addition to these global
conformational changes, protease cleavage leads to localized
changes in the environment of the thioester bond that are
likely to lead to its activation. In the unactivated SaA2M
structure the conserved methionine and tyrosine side chains
(Met1625 and Tyr1626 in SaA2M) from the CTMG domain
form part of the hydrophobic pocket at the interface with the
TED that has been shown to be important in maintenance of
the thioester bond (Wong & Dessen, 2014). The loss of these
key side-chain interactions and the movement of the addi-
tional side chains which constitute the protective hydrophobic
pocket (Tyr1175 and Tyr1177 in SaA2M and Tyr1183 and
Tyr1185 in ECAM) from the TED exposes the thioester bond
to the solvent, allowing hydrolysis or covalent-bond formation
with the attacking protease (Fig. 4b). As there are no contacts
present from the CTMG domain providing a hydrophobic
pocket to protect the thioester from hydrolysis by water, the
thioester bond could be cleaved and the deaminated gluta-
mine (Gln1190) would be converted to a glutamic acid. Within
our protease-activated ECAM structure the distance between
the S atom of Cys1187 and the C atom of Gln1190 is 4.6 A˚,
indicating that the thioester bond may not be intact (Supple-
mentary Fig. S2). However, we cannot rule out the possibility
that there is a mixed population of molecules, some of which
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Figure 3
Sequence alignments of conserved motifs involved in the thioester pocket and conformational activation. Highlighted in yellow are tyrosines important
for maintaining the hydrophobic pocket protecting the thioester bond (CLEQ motif, also shown in yellow). The tyrosine within the C-terminal
macroglobulin (CTMG) domain, involved in protecting the thioester, which coordinates to the glutamate within the CLEQ motif in the native SaA2M
structure is highlighted in blue (PDB entry 4u48). The conserved proline found near the thioester is highlighted in green along with the arginine that it
coordinates in unactivated SaA2M. The residues highlighted in pink, orange and red in the CTMG domain coordinate to residues Asn963, Gly958 and
Arg956, respectively, in the cleaved bait region of elastase-cleaved ECAM.
possess an intact thioester bond. Owing to this ambiguity, we
have represented the thioester without a covalent bond
between Cys1187 and the C atom of Gln1190 and have also
omitted the O atom from the deaminated glutamine that
would be formed on hydrolysis of the thioester bond.
4. Discussion
Although it has been suggested that small-molecule-activated
human 2M resembles the conformation of the protease-
cleaved form, there have to date been no detailed structural
data to confirm this (Tapon-Bretaudie´re et al., 1985). The
similarity in the overall conformation of protease-cleaved
ECAM to that of methylamine-activated human 2M confirms
that the protease-activated and chemically activated forms of
human 2M are structurally equivalent. In addition, these data
suggest that the entrapment of cleaving proteases is likely to
occur in a similar manner for BA2Ms as has been proposed
for human 2M (Marrero et al., 2012; Meyer et al., 2012).
However, there are clearly key differences in the details of the
interactions that maintain the inactive conformations of
BA2Ms and human 2M, since the recent structures of
unactivated and methylamine-activated SaA2M show that
chemical cleavage of the thioester bond does not lead to
global conformational changes in this case (Marrero et al.,
2012; Wong & Dessen, 2014). This difference is likely to be
owing to the domain location of the side chains that comprise
the thioester-protecting pocket (Supplementary Fig. S3). In
BA2Ms this pocket comprises two tyrosine side chains from
the TED and a tyrosine and a methionine side chain from the
CTMG domain, whereas in eukaryotic 2Ms all four residues
(three tyrosine side chains and one methionine side chain) are
found in the CTMG domain. When SaA2M is reacted with
methylamine no conformational change is seen, but Tyr1175
from the TED is displaced (Wong & Dessen, 2014). The
structural counterpart of this side chain (Tyr1307 from TEP1)
in eukaryotic 2M family members is, however, found within
the CTMG domain (Supplementary Fig. S3; Baxter et al.,
2007). It is presumably the rearrangement of this side chain
and perhaps other CTMG side chains that comprise the
thioester-protecting pocket which leads to the loss of TED–
CTMG domain binding and subsequent global conformational
changes. The buried surface area seen between the TED and
the CTMG domain in native SaA2M decreases by 27%
compared with that of the BRD and the CTMG domain in
protease-cleaved ECAM; however, the number of hydrogen
bonds increases. Although there is a decrease in the buried
surface area, it is the interaction between important residues
for protecting the thioester that would be expected to trigger
conformational change releasing TED and allow subsequent
interaction with a cleaving protease.
The role of BA2Ms, which are inner membrane-anchored
periplasmic proteins, has been suggested as protease inhibitors
that inhibit exogenous proteases that have breached the outer
membrane. Comparison of the structures of unactivated
SaA2M and protease-cleaved ECAM illustrates how protease-
induced conformational changes enable protease entrapment
(Fig. 5). The movement of the TED-domain arm and MG6-
domain arm around the central pocket above the bait region
is similar to the movement seen in methylamine-activated
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Figure 4
Conformational shift of the TED and thioester of protease-activated ECAM. (a) Superposition of protease-cleaved ECAM (red) and SaA2M (blue)
showing a 36 A˚ shift of the TED. Structures were overlaid by superposition of MG8 containing the BRD. (b) Overlaid elastase-cleaved ECAM (red) and
native SaA2M (blue) TEDs. Tyrosines thought to protect the thioester region from hydrolysis in native SaA2M (Tyr1175 and Tyr1177) are orientated
away from the protease-activated ECAM thioester region (Tyr1183 and Tyr1185 in protease-activated ECAM).
human 2M; when accounting for the domains that are not
present in the protease-activated ECAM structure no clashes
are seen between the moving arms and the absent domains
(Marrero et al., 2012). The entrapment of proteases would
limit the proteolysis to smaller substrates, as has been
suggested for human 2M, and would prevent the cleavage of
important larger substrates such as the peptide component of
the peptidoglycan layer or large proteins (Fig. 5; Sottrup-
Jensen, 1989). Although we cannot be sure why the covalently
bound elastase is not present in our structure, this may be
owing to a lack of available and correctly positioned lysine
side chains on the surface of the protease, since the thioester
bond is preferentially cleaved by this side chain (Marrero et
al., 2012). The lack of MG domains 1, 2, 3 and 7 within the
crystal lattice is likely to be owing to the MG domains being
cleaved by the elastase.
In summary, the structure of protease-activated ECAM
shows a competitive mechanism of activation in which clea-
vage of the BRD allows the normally intrinsically disordered
region of this domain to outcompete the TED for CTMG-
domain binding. Loss of the TED–CTMG domain interaction
leads to a large conformational rearrangement of ECAM and
exposure of the reactive thioester bond. The structural simi-
larity between methylamine-activated human 2M and
protease-cleaved ECAM suggests that similar mechanisms are
likely to operate across the diverse members of the 2M
family.
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